Overview Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients Status: Completed Trial end date: 2010-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate if DE-101 ophthalmic suspension will safely and effectively improve signs and or symptoms of dry eye disease. Phase: Phase 1/Phase 2 Details Lead Sponsor: Santen Inc.